GSK Investigational Site is a clinical research site located in Greer, South Carolina, United States 29651.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 47 clinical trials.
Therapeutic areas: Hypertrophy, Left Ventricular, Neoplasms, Prostate, Pulmonary Disease, Chronic Obstructive.
Sponsors: GlaxoSmithKline, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), XenoPort, Inc..
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 47 clinical trials on record. Their work covers Hypertrophy, Left Ventricular, Neoplasms, Prostate, Pulmonary Disease, Chronic Obstructive.
Yes — GSK Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.